Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema.

Fortis S, Guo J, Nagpal P, Chaudhary MFA, Newell JD, Gerard SE, Han MK, Kazerooni EA, Martinez FJ, Barjaktarevic IZ, Barr RG, Bodduluri S, Paine R, Awan HA, Schroeder JD, Gravens-Mueller LD, Ortega VE, Anderson WH, Cooper CB, Couper D, Woodruff PG, Bowler RP, Bhatt SP, Hoffman EA, Reinhardt JM, Comellas AP. Association of Ground-Glass Opacities with Systemic Inflammation and Progression of Emphysema. American journal of respiratory and critical care medicine. 2024 Dec 15; 210(12):1432-1440.

Dimensions for VA is a web-based tool available to VA staff that enables detailed searches of published research and research projects.

If you have VA-Intranet access, click here for more information vaww.hsrd.research.va.gov/dimensions/

VA staff not currently on the VA network can access Dimensions by registering for an account using their VA email address.    Search Dimensions for VA for this citation
* Don't have VA-internal network access or a VA email address? Try searching the free-to-the-public version of Dimensions

Search for Abstract from PubMed

---

Abstract:

Ground-glass opacities (GGOs) in the absence of interstitial lung disease are understudied. To assess the association of GGOs with white blood cells (WBCs) and progression of quantified chest computed tomography emphysema. We analyzed data of participants in the SPIROMICS study (Subpopulations and Intermediate Outcome Measures in COPD Study). Chest radiologists and pulmonologists labeled regions of the lung as GGOs, and the adaptive multiple feature method (AMFM) trained the computer to assign those labels to image voxels and quantify the volume of the lung with GGOs (%GGO). We used multivariable linear regression, zero-inflated negative binomial, and proportional hazards regression models to assess the association of %GGO with WBCs, changes in percentage emphysema, and clinical outcomes. Among 2,714 participants, 1,680 had chronic obstructive pulmonary disease (COPD) and 1,034 had normal spirometry. Among participants with COPD, on the basis of multivariable analysis, current smoking and chronic productive cough were associated with higher %GGO. Higher %GGO was cross-sectionally associated with higher WBC and neutrophil concentrations. Higher %GGO per interquartile range at visit 1 (baseline) was associated with an increase in emphysema at 1-year follow-up visit by 11.7% (relative increase; 95% confidence interval, 7.5-16.1%; ? < 0.001). We found no association between %GGO and 1-year FEV decline, but %GGO was associated with exacerbations and all-cause mortality during a median follow-up of 1,544?days (interquartile interval, 1,118-2,059). Among normal spirometry participants, we found similar results, except that %GGO was associated with progression to COPD at 1-year follow-up. Our findings suggest that GGO is associated with increased systemic inflammation and emphysema progression.